Nasdaq

Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris®

SALT LAKE CITY, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN) a leader in genetic testing and precision medicine, today announced the integration of Absolute Risk Reduction ...
ascopubs.org

Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate Cancer

Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients With Advanced Prostate Cancer From Latin America: Challenges and Future Approaches A model of absolute risk ...
The American Journal of Managed Care

Vitamin D Linked to Reduced Diabetes Risk in Adults With Prediabetes

Adjusted analyses showed vitamin D reduced diabetes risk by 15%, with a 3-year absolute risk reduction of 3.3%. Vitamin D has been shown to decrease the risk of diabetes in adults with prediabetes, ...

Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial

Tigris trialMortality at 12 months was 52.8% with PMX vs. 66.7% with standard of care alone (absolute risk reduction of ...
Medscape

Romosozumab Use in Osteoporosis May Cut Osteoarthritis Risk

Romosozumab use in adults with osteoporosis was associated with a 21% reduction in risk for osteoarthritis, particularly knee osteoarthritis, compared with teriparatide use. Researchers used a ...